HQL-79
HQL-79 is a selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor. It inhibits the synthesis of PGD2 and acts as an anti-allergic agent (Kd: 0.8 μM and IC50: 6 μM) . It also shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS.
Product Specifications
CAS Number
162641-16-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
377.48
Molecular Formula
C22H27N5O
Notes
Research use only, not for human use.
Receptor
Other Targets
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog